Delivery Order SPE2DB24D6041-SPE2DB25FKCQE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) under a firm fixed-price contract valued at $2,458.96. The award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency has awarded a delivery order valued at $2,401.31 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets in quantities of 30 units. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is scheduled for completion by June 20, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a $1,672.35 delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Armodafinil 250 mg tablets in quantities of 30 units. This is a firm fixed price contract with an ultimate completion date of July 11, 2025, and represents a non-competitive set-aside award. The contract is performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a leading pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,779.24 to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) under a firm fixed-price contract valued at $11,605.05, with an ultimate completion date of September 22, 2025. This competitively awarded, non-set-aside delivery order leverages AmerisourceBergen's established pharmaceutical supply relationship with the federal government. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a...
- The Defense Logistics Agency awarded a delivery order valued at $1,672.50 to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count supply) on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count) under a firm fixed-price contract valued at $2,843.06, with a completion date of June 3, 2025. This non-set-aside award was competitively issued and reflects the continuation of pharmaceutical procurement through established federal contract vehicles. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,672.35 delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Armodafinil 250 mg, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be performed from the contractor's facility in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency has awarded a delivery order valued at $1,672.50 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units). This competitive, firm fixed-price delivery order was executed on September 18, 2025, with an ultimate completion date of September 19, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,115.00 to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count packages) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed price, non-set-aside contract will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB24D6041Indefinite Delivery Contract
- SPE2DB24D6041-SPE2DB25FKCQEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count supply) with a ceiling value of $2,024.58. This non-set-aside, competitively awarded contract employs firm fixed price pricing and is scheduled for completion by September 16, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same area. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This prime contract vehicle supports the Defense Health Agency and other federal healthcare systems by providing comprehensive pharmaceutical products and medical supplies globally. The parent IDC demonstrates AmerisourceBergen's significant capacity to serve military healthcare programs, with the company competing successfully across open market procurements for diverse medication categories ranging from specialty treatments to generic pharmaceuticals.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/15/25 |